We are live on ! Find out more
PACB icon

Pacific Biosciences
PACB

94 hedge funds and large institutions have $230M invested in Pacific Biosciences in 2015 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 32 increasing their positions, 29 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 29

7% less funds holding

Funds holding: 101 → 94 (-7)

32% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 19

33% less capital invested

Capital invested by funds: $342M → $230M (-$112M)

34% less call options, than puts

Call options by funds: $107K | Put options by funds: $162K

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
94
Holders Change
-7
Holders Change %
-6.93%
% of All Funds
2.51%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
13
Increased
32
Reduced
29
Closed
19
Calls
$107K
Puts
$162K
Net Calls
-$55K
Net Calls Change
-$342K

Top Buyers

1
CCM
Consonance Capital Management
New York
+$13.8M
2
NI
Numeric Investors
Massachusetts
+$5.4M
3
MC
Maverick Capital
Texas
+$4.15M
4
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$3.25M
5
BIT
BlackRock Institutional Trust
California
+$2.59M

Top Sellers

1
DM
Deerfield Management
New York
-$14.3M
2
BA
BlackRock Advisors
Delaware
-$2.57M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$2.47M
4
BCM
Bridgeway Capital Management
Texas
-$1.95M
5
RG
Redmile Group
California
-$1.87M
Name Holding Trade Value Shares
Change 		Change in
Stake
MC
1
Maverick Capital
Texas
$41.2M +$4.15M +601,250 +9%
OIM
2
Oracle Investment Management
Connecticut
$19.2M +$374K +54,278 +2%
DM
3
Deerfield Management
New York
$17.8M -$14.3M -2,072,461 -40%
BA
4
BlackRock Advisors
Delaware
$16.3M -$2.57M -373,193 -12%
BFA
5
BlackRock Fund Advisors
California
$15M +$847K +122,799 +5%
Blackstone Inc
6
Blackstone Inc
New York
$14.1M – – –
Millennium Management
7
Millennium Management
New York
$12.7M +$13K +1,889 +0.1%
CCM
8
Consonance Capital Management
New York
$11.7M +$13.8M +2,002,971 New
Vanguard Group
9
Vanguard Group
Pennsylvania
$10.6M +$1.31M +190,484 +12%
BIT
10
BlackRock Institutional Trust
California
$6.67M +$2.59M +376,238 +49%
NI
11
Numeric Investors
Massachusetts
$5.45M +$5.4M +783,517 +526%
State Street
12
State Street
Massachusetts
$4.69M +$200K +28,941 +4%
Northern Trust
13
Northern Trust
Illinois
$3.59M +$27.1K +3,935 +0.6%
BG
14
BlackRock Group
United Kingdom
$3.22M -$653K -94,691 -15%
PAM
15
Panagora Asset Management
Massachusetts
$3.1M +$731K +106,081 +25%
Fuller & Thaler Asset Management
16
Fuller & Thaler Asset Management
California
$2.88M -$11K -1,600 -0.3%
Lord, Abbett & Co
17
Lord, Abbett & Co
New Jersey
$2.75M +$3.25M +471,153 New
MOACM
18
Mutual of America Capital Management
New York
$2.53M +$37.3K +5,412 +1%
California Public Employees Retirement System
19
California Public Employees Retirement System
California
$2.27M – – –
BIM
20
BlackRock Investment Management
Delaware
$2.18M +$95.2K +13,803 +4%
Geode Capital Management
21
Geode Capital Management
Massachusetts
$2.13M +$152K +22,072 +6%
D.E. Shaw & Co
22
D.E. Shaw & Co
New York
$2.06M -$2.47M -357,797 -50%
Bank of New York Mellon
23
Bank of New York Mellon
New York
$2.05M +$134K +19,424 +6%
Dimensional Fund Advisors
24
Dimensional Fund Advisors
Texas
$1.96M -$1.11M -161,105 -32%
OAM
25
Oxford Asset Management
United Kingdom
$1.77M +$2.09M +302,982 New
1
2 3 4 5

PACB Hedge Fund Activity: Q1 2015 in Review

94 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Pacific Biosciences (PACB) for Q1 2015, worth a combined $230M — down 33% from $342M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of PACB and 13 opened new positions — a net loss of 6 holders — while 29 trimmed existing stakes and 32 added.

The largest buyer was Consonance Capital Management, opening a new position worth an estimated $13.8M. The largest seller was Deerfield Management, cutting an estimated $14.3M.

  • 94 institutional investors held Pacific Biosciences (PACB) as of Q1 2015, down from 101 in Q4 2014.
  • Funds reported $230M of Pacific Biosciences stock for Q1 2015, down 33% quarter-over-quarter.
  • 13 funds opened new Pacific Biosciences positions in Q1 2015 and 19 closed out, a net change of -6 holders.
  • The largest Pacific Biosciences buyer in Q1 2015 was Consonance Capital Management, an estimated $13.8M added.
  • The largest Pacific Biosciences seller in Q1 2015 was Deerfield Management, an estimated $14.3M sold.

Based on aggregated 13F filings for Q1 2015.